TNFRSF10B and neoplasm: A special plasmid was designed for this study (one combined plasmid pKR-p53) that simultaneously expresses p53 proteins and KillerRed (a novel protein especially capable of generating ROS under green light irradiation) in the same tumor cell having a synergistic tumor therapy.